BioHealth News Archive

Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members

Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members

FREDERICK, Md., June 16, 2021 /PRNewswire/ -- Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with…

Read More
National Academy of Inventors

National Academy of Inventors

This is the annual report published by the National Academy of Inventors (NAI) and the Intellectual Property Owners Association (IPO) on top university patent…

Read More

Novavax Plans FDA Filing for COVID-19 Vaccine after Positive Efficacy Data

Novavax said today it will file for FDA approvals in the third quarter for its COVID-19 vaccine NVX-CoV2373, after it showed 90.4% overall efficacy,…

Read More
Laboratory Technician – RNA Therapeutics Development in Gaithersburg, Maryland | BioBuzz Job Board

Laboratory Technician – RNA Therapeutics Development in Gaithersburg, Maryland | BioBuzz Job Board

Starting immediately, miRecule, Inc. is looking for a Laboratory Technician to join its rapidly growing team in Gaithersburg, MD on the development of next…

Read More
New opportunities for students in science education; collaborative effort in Montgomery Co. | WDVM25 & DCW50 | Washington, DC

New opportunities for students in science education; collaborative effort in Montgomery Co. | WDVM25 & DCW50 | Washington, DC

ROCKVILLE, Md. (WDVM) — More opportunities to come for college students in Maryland who are interested in STEM-related fields. Montgomery County is playing a…

Read More
Q&A: Cushman & Wakefield’s Dan Hackett on Life Sciences Trends – Commercial Observer

Q&A: Cushman & Wakefield’s Dan Hackett on Life Sciences Trends – Commercial Observer

The life sciences sector is hot, and that’s led to a rising interest among building owners in converting assets to lab, research and biotech…

Read More
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial | Novavax Inc. – IR Site

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial | Novavax Inc. – IR Site

93% efficacy against predominantly circulating Variants of Concern and Variants of Interest  91% efficacy in high-risk populations  100% efficacy against variants "not considered Variants…

Read More
Will the Biotech Industry Have the Right Talent for the Workforce of the Future? · BioBuzz

Will the Biotech Industry Have the Right Talent for the Workforce of the Future? · BioBuzz

A few weeks ago, we wrote about how the BioHealth Capital Region’s (BHCR) biotech sector is booming. Advanced biomanufacturing, cell and gene therapy, vaccine…

Read More
Novavax nearly ready to report latest Covid-19 vaccine trial data – Washington Business Journal

Novavax nearly ready to report latest Covid-19 vaccine trial data – Washington Business Journal

The Gaithersburg biotech expects more data on its latest vaccine trial within days. Image: Novavax's future headquarters is located at 700 Quince Orchard Road…

Read More
Montgomery County, University System of Maryland, Montgomery College sign deal to work on life sciences innovation – Washington Business Journal

Montgomery County, University System of Maryland, Montgomery College sign deal to work on life sciences innovation – Washington Business Journal

Maryland universities, Montgomery County government and the private sector are teaming up to capitalize on local momentum in life sciences created over the past…

Read More

Novavax Offers U.S. a Fourth Strong Covid-19 Vaccine – The New York Times

Novavax, a small American company buoyed by lavish support from the U.S. government, announced on Monday the results of a clinical trial of its…

Read More
Biden wants $6.5 billion for new health agency to speed treatments | Science | AAAS

Biden wants $6.5 billion for new health agency to speed treatments | Science | AAAS

The Biden administration today began to flesh out a proposal for a new agency—modeled on the military’s Defense Advanced Research Projects Agency (DARPA)—that would…

Read More
BHI EIR Feedback Day July 21st. Register Now!

BHI EIR Feedback Day July 21st. Register Now!

Are you a biohealth start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your…

Read More
Additional EiRs for SEED

Additional EiRs for SEED

BioHealth Innovation, Inc. (BHI), is a Montgomery County innovation intermediary that translates market-relevant research into commercial success by bringing together management, funding, and markets.…

Read More
Targeting Metabesity 2021 – ACCELERATING ADVANCEMENTS IN GEROSCIENCE INTO​MATERIAL AND EQUITABLE GAINS IN PUBLIC HEALTH

Targeting Metabesity 2021 – ACCELERATING ADVANCEMENTS IN GEROSCIENCE INTO​MATERIAL AND EQUITABLE GAINS IN PUBLIC HEALTH

I am delighted to announce that FREE Registration is open for the annual Conference, Targeting Metabesity2021, organized by our colleagues Kinexum and the Kitalys…

Read More